Massimiliano Fambrini

No ORCID on file · 32 papers in corpus · active 2009-2026

Study types

  • article 13
  • other 7
  • review 4
  • book-chapter 2
  • case-report 1

Condition tags

  • endometriosis 19
  • adenomyosis 8
  • infertility 6
  • dysmenorrhea 6
  • endometrioma 1
  • die_deep_infiltrating 1
  • dyspareunia 1
other 2026
F&S science ·doi:10.1016/j.xfss.2026.03.001

OBJECTIVE: To assess the prevalence of proliferative endometrial disorders in women with histologically confirmed adenomyosis and to evaluate the independent association between adenomyosis and each lesion type. DESIGN: Retrospective cohor…

2026
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2026.2692730

BACKGROUND: Adenomyosis is a benign uterine disease that has been associated with endometrial proliferative disorders. Adenomyosis and endometrial cancer (EC) are sex-steroid-dependent conditions that may coexist, but their estrogen recepto…

article 2026
·doi:10.6084/m9.figshare.32760643.v1

Adenomyosis is a benign uterine disease that has been associated with endometrial proliferative disorders. Adenomyosis and endometrial cancer (EC) are sex-steroid-dependent conditions that may coexist, but their estrogen receptor (ER) and p…

article 2026
·doi:10.6084/m9.figshare.32760643

Adenomyosis is a benign uterine disease that has been associated with endometrial proliferative disorders. Adenomyosis and endometrial cancer (EC) are sex-steroid-dependent conditions that may coexist, but their estrogen receptor (ER) and p…

other 2025
Gynecologic oncology ·doi:10.1016/j.ygyno.2025.02.017

BACKGROUND/OBJECTIVE: Adenomyosis is a benign uterine disorder characterized by an inflammatory and hyperestrogenic state. Its association with endometrial cancer (EC) remains controversial. This study aimed to investigate the correlation b…

other 2025
Frontiers in reproductive health ·doi:10.3389/frph.2025.1697567

Autoimmune and inflammatory rheumatic diseases (RDs) are more prevalent in women and often affect gynecological health. Particularly, heavy menstrual bleeding (HMB) and dysmenorrhea are more common in patients with RD. A link between RDs an…

review 2025
Expert opinion on pharmacotherapy ·doi:10.1080/14656566.2025.2451145

INTRODUCTION: Dysmenorrhea is a painful symptom associated with uterine contractions and menstrual bleeding and is treated by administering analgesic drugs. Since progesterone receptors (PRs) have a major role in regulating uterine tissues …

other 2025
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2025.105102

RESEARCH QUESTION: How do comorbidities and their prevalence differ between patients with adenomyosis alone and patients with both adenomyosis and endometriosis? DESIGN: A prospective observational study compared the presence of comorbidit…

article 2024
·doi:10.1136/ijgc-2024-esgo.83
other 2024
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.103768

RESEARCH QUESTION: What is the prevalence of adenomyosis at ultrasonography among adolescents and young women reporting dysmenorrhoea and/or heavy menstrual bleeding (HMB)? DESIGN: This observational cohort study involved adolescents and y…

review 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102507

Adenomyosis is a common benign uterine disorders and patients may present dysmenorrhea, dyspareunia, abnormal uterine bleeding (AUB) and infertility. The treatment is very complex, including medical, surgical or radiological approaches. Hor…

other 2024
The FEBS journal ·doi:10.1111/febs.17071

Endometriosis is a chronic gynecological syndrome characterized by endometrial cell invasion of the extra-uterine milieu, pelvic pain and infertility. Treatment relies on either symptomatic drugs or hormonal therapies, even though the mecha…

article 2024
·doi:10.21608/jrme.2024.260072.1002

Endometriosis, a chronic gynecological disease, affects millions of women worldwide, significantly impacting their quality of life. A reported delay, ranging from 4 to 12 years, exists between the onset of symptoms and the formal diagnosis.…

article 2022
·doi:10.1007/s13669-022-00326-7

Abstract Purpose of the Review The purpose of this review is to provide a synopsis of all the mechanisms involved in the pathogenesis of adenomyosis. It will summarize recent advances in the field, discussing current controversies, and cons…

other 2022
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2022.07.004

STUDY OBJECTIVE: To investigate the clinical and surgical predictors of urinary tract endometriosis (UTE) relapse. DESIGN: Retrospective single institutional study. SETTING: Italian multidisciplinary referral center for endometriosis. PA…

2021
Scientific reports ·doi:10.1038/s41598-021-98336-7

Female sexual dysfunction (FSD) may be a mirror of a poor cardiometabolic state. In a small pilot study enrolling 71 women with FSD, we previously demonstrated that clitoral Pulsatility Index (PI) evaluated by using color Doppler ultrasound…

article 2021
Minerva obstetrics and gynecology ·doi:10.23736/s2724-606x.21.04757-2

INTRODUCTION: The relationship between endometrioma and ovarian cancer is a topic of discussion in the field of endometriosis and to date it is still debated whether ovarian endometriosis may represent a risk factor for ovarian cancers. EVI…

book-chapter 2020
·doi:10.1007/978-3-030-57866-4_5
review 2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00226-2

Endometriosis is an estrogen-dependent inflammatory gynecological disease. Increased estrogen activity and progesterone resistance are the main hormonal substrate of this disease and are associated with inflammatory response and debilitatin…

book-chapter 2019
·doi:10.1007/978-3-030-14358-9_14
2019
Oncology reports ·doi:10.3892/or.2018.6939

Endometrial cancer (EC) comprises a biological and clinical heterogeneous group of tumors. Several genetic alterations are involved in the development and progression of EC, and may be used for targeted therapy, particularly in patients wit…

review 2018
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2018.01.021

Endometriosis is a chronic disease, and a lifelong management plan should be developed by using pharmacological treatment and surgical procedures. The pathogenesis of endometriosis is complicated and has not been definitively established. T…

2018
The American journal of case reports ·doi:10.12659/ajcr.909635

BACKGROUND Uterine arteriovenous malformation (AVM) is an uncommon lesion characterized by an abnormal connection between arterial and venous circulation that can be congenital or acquired. Acquired uterine AVMs are generally traumatic and …

article 2016
·doi:10.3389/fonc.2016.00190

INTRODUCTION: A 51 year-old woman was diagnosed with endometrial cancer (EC) and underwent surgical staging. Pathological evaluation showed a 2 cm × 1 cm G2 endometrioid EC with a 30% myometrial deep invasion (FIGO Stage 1A). The patient wa…

article 2016
Archives of gynecology and obstetrics ·doi:10.1007/s00404-016-4222-7

PurposeThe main aim of this study was to evaluate the incidence of endometriosis and intrahepatic cholestasis (ICP) and induction of labor in pregnant women with endometriosis compared with women without endometriosis. The secondary aim was…